Clinical Trial Update: Phase 1 Trial of BTM-3566 in Relapsed/Refractory Mature B Cell Lymphomas [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating BTM-3566 in relapsed/refractory mature B-cell lymphomas is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma

Drugs mentioned

• BTM-3566 (BTM-3566)

Snippet

Sponsor: Bantam Pharmaceuticals | Conditions: Lymphoma, B-Cell | Phase 1 | Status: RECRUITING